Interestingly, Tα1 showed beneficial effects either in the acute COVID-19 phase or in reinfection even in elderly patients (89), thus pointing to a potential immunorestorative effect of Tα1 in aging, as suggested (104). This evidence concerns the gene TAAR1 and COVID-19.